Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase 2 7Phase 1/2 4Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Multiple Myeloma 4Renal Insufficiency 1Primary Myelofibrosis 1Neoplasms, Plasma Cell 1Myeloproliferative Disorders 1Lymphoma, B-Cell 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia 1Breast Neoplasms 1

Interventions

fludarabine 1Transplantation 1Tablets 1Stem Cell Transplantation 1Roflumilast 1Pemetrexed 1Nadolol 1Isoproterenol 1Introns 1FANG vaccine 1Exercise 1Cyclophosphamide 1Counseling 1Cord Blood Stem Cell Transplantation 1Carvedilol 1Bortezomib 1Bisoprolol 168Ga-pentixafor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Leukemia × Bortezomib × Clear all
NCT00437086 2014-10-17

Bortezomib in Treating Patients With Advanced Myeloproliferative Disorders

Mayo Clinic

Phase EARLY_PHASE1 Completed
30 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡